Flavio-Reis V, Pessoa-Goncalves Y, Diaz C, Lamoglia A, Desiderio C, Oliveira C
Pain Manag. 2025; 15(3):149-160.
PMID: 39962721
PMC: 11881878.
DOI: 10.1080/17581869.2025.2467025.
Huh J, Kim M, Noh Y, Seo H, Lee D
J Clin Med. 2024; 13(2).
PMID: 38256472
PMC: 10815972.
DOI: 10.3390/jcm13020338.
Huh J, Kim M, Noh Y, Seo H, Lee D
BMC Surg. 2023; 23(1):227.
PMID: 37563582
PMC: 10413713.
DOI: 10.1186/s12893-023-02138-9.
Hasan S, Gendra R, James J, Morris D, Orenstein L, Ingram J
Br J Dermatol. 2022; 187(6):846-854.
PMID: 35962565
PMC: 10087046.
DOI: 10.1111/bjd.21821.
Sleczkowska M, Almomani R, Marchi M, de Greef B, Sopacua M, Hoeijmakers J
Int J Mol Sci. 2022; 23(13).
PMID: 35806193
PMC: 9266298.
DOI: 10.3390/ijms23137190.
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review.
Dodick D, Goadsby P, Ashina M, Tassorelli C, Hundemer H, Bardos J
Headache. 2022; 62(4):453-472.
PMID: 35363381
PMC: 9325511.
DOI: 10.1111/head.14292.
Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy.
Geerts M, de Greef B, Sopacua M, van Kuijk S, Hoeijmakers J, Faber C
Neurology. 2021; 96(20):e2534-e2545.
PMID: 33766992
PMC: 8205474.
DOI: 10.1212/WNL.0000000000011919.
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations.
Smith S, Dworkin R, Turk D, McDermott M, Eccleston C, Farrar J
Pain. 2020; 161(11):2446-2461.
PMID: 32520773
PMC: 7572524.
DOI: 10.1097/j.pain.0000000000001952.
Treatment Outcomes in Trigeminal Neuralgia-A Systematic Review of Domains, Dimensions and Measures.
Nova C, Zakrzewska J, Baker S, Riordain R
World Neurosurg X. 2020; 6:100070.
PMID: 32123867
PMC: 7036566.
DOI: 10.1016/j.wnsx.2020.100070.
Tai Chi for rheumatoid arthritis.
Mudano A, Tugwell P, Wells G, Singh J
Cochrane Database Syst Rev. 2019; 9:CD004849.
PMID: 31553478
PMC: 6759565.
DOI: 10.1002/14651858.CD004849.pub2.
An Assessment of Clinically Important Differences on the Worst Pain Severity Item of the Modified Brief Pain Inventory in Patients with Diabetic Peripheral Neuropathic Pain.
Marcus J, Lasch K, Wan Y, Yang M, Hsu C, Merante D
Pain Res Manag. 2018; 2018:2140420.
PMID: 30140328
PMC: 6081576.
DOI: 10.1155/2018/2140420.
An eHealth program versus a standard care supervised health program and associated health outcomes in individuals with mobility disability: study protocol for a randomized controlled trial.
Berglind D, Nyberg G, Willmer M, Persson M, Wells M, Forsell Y
Trials. 2018; 19(1):258.
PMID: 29703242
PMC: 5923004.
DOI: 10.1186/s13063-018-2646-z.
Patient-Reported Outcomes and Opioid Use by Outpatient Cancer Patients.
Moryl N, Dave V, Glare P, Bokhari A, Malhotra V, Gulati A
J Pain. 2017; 19(3):278-290.
PMID: 29154919
PMC: 5811357.
DOI: 10.1016/j.jpain.2017.11.001.
Independent validation of the Pain Management Plan in a multi-disciplinary pain team setting.
Quinlan J, Hughes R, Laird D
Br J Pain. 2016; 10(4):168-176.
PMID: 27867506
PMC: 5102097.
DOI: 10.1177/2049463716657366.
Comparison of 2 Multimodal Interventions With and Without Whole Body Vibration Therapy Plus Traction on Pain and Disability in Patients With Nonspecific Chronic Low Back Pain.
Maddalozzo G, Kuo B, Maddalozzo W, Maddalozzo C, Galver J
J Chiropr Med. 2016; 15(4):243-251.
PMID: 27857632
PMC: 5106425.
DOI: 10.1016/j.jcm.2016.07.001.
Clinical effectiveness of a residential pain management programme - comparing a large recent sample with previously published outcome data.
Smith J, Knight L, Stewart A, Smith E, McCracken L
Br J Pain. 2016; 10(1):46-58.
PMID: 27551411
PMC: 4977965.
DOI: 10.1177/2049463715601445.
Intravenous immunoglobulin therapy for small fiber neuropathy: study protocol for a randomized controlled trial.
de Greef B, Geerts M, Hoeijmakers J, Faber C, Merkies I
Trials. 2016; 17(1):330.
PMID: 27439408
PMC: 4955261.
DOI: 10.1186/s13063-016-1450-x.
Duloxetine for the Treatment of Patients with Suspected Sphincter of Oddi Dysfunction: A Pilot Study.
Pauls Q, Durkalski-Mauldin V, Brawman-Mintzer O, Lawrence C, Whichard R, Cotton P
Dig Dis Sci. 2016; 61(9):2704-9.
PMID: 27165434
DOI: 10.1007/s10620-016-4187-1.
Randomized phase II study of loratadine for the prevention of bone pain caused by pegfilgrastim.
Moukharskaya J, Abrams D, Ashikaga T, Khan F, Schwartz J, Wilson K
Support Care Cancer. 2016; 24(7):3085-93.
PMID: 26894485
PMC: 5266505.
DOI: 10.1007/s00520-016-3119-0.
Chondroitin for osteoarthritis.
Singh J, Noorbaloochi S, MacDonald R, Maxwell L
Cochrane Database Syst Rev. 2015; 1:CD005614.
PMID: 25629804
PMC: 4881293.
DOI: 10.1002/14651858.CD005614.pub2.